Pretreatment with pathway inhibitors (FAKi, LY294002, Wortmannin, Akti, TPCK, and PDTC) clearly inhibited cell migration and VCAM-1 expression in osteosarcoma cells (Figure 5A,B). Here, VCAM1 is linked to osteosarcoma.